Approach

Innovative Solutions to
Unmet Medical Needs

Innovative Solutions to Unmet Medical Needs

We are an evergreen fund that invests in private and select public companies, supporting our portfolio throughout their life cycle. We are laser focused on improving patient care and working with companies addressing areas of unmet medical need. We seek to invest in innovative life science companies developing first in class or best in class treatments. We approach each investment with a long-term vision and pride ourselves on being knowledgeable and dependable partners.

We are an evergreen fund that invests in private and select public companies, supporting our portfolio throughout their life cycle. We are laser focused on improving patient care and working with companies addressing areas of unmet medical need. We seek to invest in innovative life science companies developing first in class or best in class treatments. We approach each investment with a long-term vision and pride ourselves on being knowledgeable and dependable partners.

Medtech

We look for technologies that address an unmet need for the patient, provider, or payer. This includes solutions that seek to significantly improve upon efficacy, safety, cost, or access relative to the current standard of care. We invest across the spectrum from early-stage through commercialization. We typically invest at a stage in which our expertise can be leveraged to help achieve a value inflection point.

Biotech

We look for companies led by outstanding management teams developing best in class technologies that have the potential to change standard of care. We focus on pre-clinical through proof-of-concept stage companies across therapeutic areas.

OUR TEAM

Working Together to Drive
Success for Stakeholders

Working Together to Drive Success for Stakeholders

You need more than just capital.
You need a partner.

category

medtech

status

Current

headquarters

Plymouth, Minnesota

website

HistoSonics

HistoSonics has developed a system to destroy tumors completely non-invasively. Treatment is achieved using histotripsy, a novel form of energy that is safe, extremely precise, and able to be personalized for each patient. The initial indication is for treatment of liver tumors and the system is being studied in several other types of tumors.